Given its pivotal role in cancer, miR-155 is being explored as a potential biomarker for cancer diagnosis, prognosis, and therapy. Elevated levels of miR-155 in blood or tissue samples can serve as an indicator of cancer presence and progression. Moreover, targeting miR-155 with anti-miR-155 molecules is being investigated as a therapeutic strategy to inhibit its oncogenic effects.
